SOURCE: Gilead Sciences
DESCRIPTION:
What goes into making innovative new medicines? In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.
Originally published by Gilead Sciences
KEYWORDS: NYSE: GILD, Gilead Sciences
